Type II Enteropathy-Associated T-cell Lymphoma: A Rare Report from Iran
Type II enteropathy-associated T-cell lymphoma (EATL) is a rare disease that is reported from Asia, especially from Taiwan. In this paper, we present a patient from Iran (Arab) with Type II EATL whose disease was not associated with celiac disease or Epstein-Barr virus (EBV) infection. The patient d...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Iranian Association of Gastroenterology and Hepatology, Shiraz University of Medical Sciences
2017-01-01
|
Series: | Middle East Journal of Digestive Diseases |
Subjects: | |
Online Access: | http://www.mejdd.org/index.php/mejdd/article/view/1722 |
id |
doaj-86ae322f7c5843a288a920e335c75f9e |
---|---|
record_format |
Article |
spelling |
doaj-86ae322f7c5843a288a920e335c75f9e2020-11-25T03:31:58ZengIranian Association of Gastroenterology and Hepatology, Shiraz University of Medical SciencesMiddle East Journal of Digestive Diseases2008-52302008-52492017-01-0191555710.15171/mejdd.2016.52Type II Enteropathy-Associated T-cell Lymphoma: A Rare Report from IranNeda Nozari01. Researcher, Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran 2. Shahid Rajai Hospital, Alborz University of Medical Sciences, Karaj, IranType II enteropathy-associated T-cell lymphoma (EATL) is a rare disease that is reported from Asia, especially from Taiwan. In this paper, we present a patient from Iran (Arab) with Type II EATL whose disease was not associated with celiac disease or Epstein-Barr virus (EBV) infection. The patient died due to intestinal perforation during the first chemotherapy. Type II EATL is a gastrointestinal lymphoma with poor prognosis and a high affinity for intestinal perforation. Early detection of EATL II is essential for chemotherapy prior to the onset of malnutrition symptoms.http://www.mejdd.org/index.php/mejdd/article/view/1722Non-Hodgkin lymphomaT cell lymphomaIntestinal perforation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Neda Nozari |
spellingShingle |
Neda Nozari Type II Enteropathy-Associated T-cell Lymphoma: A Rare Report from Iran Middle East Journal of Digestive Diseases Non-Hodgkin lymphoma T cell lymphoma Intestinal perforation |
author_facet |
Neda Nozari |
author_sort |
Neda Nozari |
title |
Type II Enteropathy-Associated T-cell Lymphoma: A Rare Report from Iran |
title_short |
Type II Enteropathy-Associated T-cell Lymphoma: A Rare Report from Iran |
title_full |
Type II Enteropathy-Associated T-cell Lymphoma: A Rare Report from Iran |
title_fullStr |
Type II Enteropathy-Associated T-cell Lymphoma: A Rare Report from Iran |
title_full_unstemmed |
Type II Enteropathy-Associated T-cell Lymphoma: A Rare Report from Iran |
title_sort |
type ii enteropathy-associated t-cell lymphoma: a rare report from iran |
publisher |
Iranian Association of Gastroenterology and Hepatology, Shiraz University of Medical Sciences |
series |
Middle East Journal of Digestive Diseases |
issn |
2008-5230 2008-5249 |
publishDate |
2017-01-01 |
description |
Type II enteropathy-associated T-cell lymphoma (EATL) is a rare disease that is reported from Asia, especially from Taiwan. In this paper, we present a patient from Iran (Arab) with Type II EATL whose disease was not associated with celiac disease or Epstein-Barr virus (EBV) infection. The patient died due to intestinal perforation during the first chemotherapy. Type II EATL is a gastrointestinal lymphoma with poor prognosis and a high affinity for intestinal perforation. Early detection of EATL II is essential for chemotherapy prior to the onset of malnutrition symptoms. |
topic |
Non-Hodgkin lymphoma T cell lymphoma Intestinal perforation |
url |
http://www.mejdd.org/index.php/mejdd/article/view/1722 |
work_keys_str_mv |
AT nedanozari typeiienteropathyassociatedtcelllymphomaararereportfromiran |
_version_ |
1724570562232057856 |